Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Agrees to review Moderna flu vaccine

Digest more
Top News
Overview
 · 1d · on MSN
Moderna says FDA to review its flu vaccine after reversing course
The U.S. Food and Drug Administration has reversed an earlier decision and said it will review drugmaker Moderna's application for approval of a seasonal flu vaccine, the company said in a statement W...

Continue reading

Straight Arrow News (English) on MSN · 1d
FDA to review Moderna's mRNA flu vaccine after initial rejection
 · 1d · on MSN
FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal
 · 1d
FDA reverses course and will review Moderna’s mRNA-based flu shot
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said Wednes...

Continue reading

 · 1d
FDA reverses course and will review Moderna’s mRNA flu shot, company says
 · 1d
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate
24m

Scientists test universal vaccine for cold, flu, Covid and allergies

The nasal spray works to protect the lungs of mice, and could eventually replace multiple jabs if shown to be effective and safe for humans.
1don MSN

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb 18 (Reuters) - A two-in-one mRNA vaccine developed by Moderna that targets seasonal influenza and COVID-19 produced robust and durable immune responses without safety concerns in a small mid-stage trial,
  • Privacy
  • Terms